G.Barekat Pharm (XTEH:BRKT1) FCF Yield % : 0.00 (As of May. 16, 2024)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, G.Barekat Pharm's Trailing 12-Month Free Cash Flow is IRR-3,914,387 Mil, and Market Cap is IRR0 Mil. Therefore, G.Barekat Pharm's FCF Yield % for today is 0.00%.

The historical rank and industry rank for G.Barekat Pharm's FCF Yield % or its related term are showing as below:

XTEH:BRKT1's FCF Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: -14.305
* Ranked among companies with meaningful FCF Yield % only.

G.Barekat Pharm's FCF Margin % for the quarter that ended in Mar. 2017 was -18.93%.

G.Barekat Pharm FCF Yield % Historical Data

The historical data trend for G.Barekat Pharm's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm FCF Yield % Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

FCF Yield %

-59.28

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
FCF Yield %	-	-59.28

Competitive Comparison of G.Barekat Pharm's FCF Yield %

For the Biotechnology subindustry, G.Barekat Pharm's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's FCF Yield % distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's FCF Yield % falls into.

G.Barekat Pharm FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

G.Barekat Pharm's FCF Yield % for the fiscal year that ended in Mar. 2017 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3914387	/	6602817.0726
	=	-59.28%

G.Barekat Pharm's annualized FCF Yield % for the quarter that ended in Mar. 2017 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3914387	*	1	/	6602817.0726
	=	-59.28%

G.Barekat Pharm FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

G.Barekat Pharm FCF Yield % Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines